Knight Therapeutics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GUD.TO | 0950.HK | HCM | KY4.F | 300558.SZ | 0MTD.IL | |
|---|---|---|---|---|---|---|
| Market cap | 1.11B | 638.89M | 2.42B | 7.59B | 20.76B | 178.72B |
| P/E (TTM) | 75.3 | 5.4 | 139.2 | 16.9 | 77.9 | 50.8 |
| Forward P/E | 43.5 | 7.8 | 53.7 | 17.7 | 29.2 | — |
| Price/book | 1.4 | 0.3 | 1.9 | 1.5 | 3.2 | 5.2 |
| Dividend yield | — | 6.51% | — | 2.89% | 0.31% | — |
| 1-year change | +92.81% | −41.58% | −15.99% | +2.24% | −12.57% | +46.23% |
| Today | +0.36% | +0.93% | +6.42% | +6.62% | +1.62% | +2.38% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All GUD.TO news ›Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil
Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil MONTREAL, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today it has…
More from 1 other outlet
Knight Therapeutics Announces Launch of TAVALISSE® in Brazil
Knight Therapeutics Announces Launch of TAVALISSE® in Brazil MONTREAL, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today the launch of…
Knight Therapeutics signs exclusive distribution agreement with Kyowa Kirin
Knight Therapeutics (KHTRF) announced the signing of an exclusive distribution agreement with Kyowa Kirin International, a wholly owned subsidia... Knight Therapeutics signs exclusive distribution agreement with Kyowa Kirin Knight…
How to Take Advantage of moves in (GUD)
When Investors Make Decisions in Knight Therapeutics Inc. GUD Opportunities Surface Trading Plans (Long Term) Buy near 6.40, target n/a, stop loss @ 6.37 No Short plans offered at this time. Check the time stamp on this data. Updated…
Tilray Medical Facility in Portugal Gains Approval for In-House Testing
The company says the INFARMED approval gives Tilray Medical greater control over critical quality testing, accelerates product release capabilities, and strengthens its Portugal facility as a strategic launchpad for medical cannabis supply…
Can Knight Therapeutics (TSX:GUD) Build on NIKTIMVO Approval in Brazil?
According to the company's release, ANVISA approved NIKTIMVO through an expedited process designed for rare diseases. The approval covers adults and paediatric patients who meet a minimum age and weight threshold and who have chronic…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- digitaljournal.com2
- manilatimes.net2
- markets.businessinsider.com2
- canada.stocktradersdaily.com1
- kalkinemedia.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.